Medical Condition News

RSS

Bill requiring AEDs be installed in public spaces will save countless lives across Ontario

A new provincial Bill undergoing second reading this week could have a profound effect on the outcomes of cardiac arrest and bystander CPR response in Ontario if it is passed.

6 May 2010

PTNS performed using Urgent PC Neuromodulation System to receive category 1 CPT reimbursement code

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, announced today that it has been informed that percutaneous tibial nerve stimulation (PTNS), the procedure performed using the Uroplasty Urgent PC Neuromodulation System, will receive a category 1 CPT reimbursement code. This is expected to occur when those codes are published by the Centers for Medicare and Medicaid Services, which is expected in October 2010.

6 May 2010

Swedish Cancer Institute, Elekta renew partnership to continue flow of technology, services to cancer patients

Swedish Cancer Institute and Elekta launch renewed partnership agreement to continue the flow of world-class technology, services to cancer patients in the Pacific Northwest and beyond.

From Elekta 6 May 2010

Whole grain barley products with low glycemic response provide favourable metabolic benefits

Evidence from observational studies indicates that diets rich in whole grain reduce risk of obesity and other diseases related to the metabolic syndrome e.g. type 2 diabetes and cardio-vascular disease. The mechanisms involved are only partially elucidated. Work within HEALTHGRAIN has revealed novel insights regarding some potential mechanisms.

6 May 2010

Measurement of finger temperature to assess individual's risk for CVD

Two University of Houston professors are working to help keep your heart beating stronger and longer simply by monitoring the temperature of your fingertip.

6 May 2010

Scientists analyze genetic networks of microRNAs in tumors

Genes interact in complex networks that govern cellular processes, much like people connect a social network through relationships. Researchers are now discovering how biological networks change and are rewired in cancer.

6 May 2010

Study reveals long-term advantages of fast initial weight loss

If you thought the best way to lose and maintain weight was the slow and steady approach, think again. A new study by Lisa Nackers and colleagues, from the University of Florida in the US, suggests that the key to long-term weight loss and maintenance is to lose weight quickly, not gradually, in the initial stages of obesity treatment. Their findings1 are published online in Springer's International Journal of Behavioral Medicine.

6 May 2010

Promising new generation of contact lenses for myopia control

An international team of researchers tested a contact lens that may reduce the progress of nearsightedness, or myopia, by fully correcting the central vision but reducing the relative peripheral farsightedness, or hyperopia.

6 May 2010

Phase II trial: TB-402 demonstrates superior antithrombotic activity to enoxaparin

BioInvent International AB and ThromboGenics NV announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism following orthopaedic surgery.

6 May 2010

Study confirms long-term durability of endoscopic RFA using HALO system for eradicating Barrett's esophagus

Results from two major multi-center clinical trials presented at the Digestive Disease Week in New Orleans independently confirmed that the effects of endoscopic radiofrequency ablation (RFA) for eradicating a pre-cancerous condition of the esophagus called Barrett's esophagus are durable in the long-term. In a plenary scientific presentation titled "Endoscopic Radiofrequency Ablation for Barrett's Esophagus: Five-year Durability Outcomes from a Prospective Multi-Center Trial," patients with Barrett's esophagus were treated with endoscopic RFA using the HALO system.

6 May 2010

New film on depression, drugs and alternative paths to better mental health

A new film on depression, drugs and alternative paths to better mental health will premiere Wednesday, May 12th at UltraStar Cinemas in Del Mar, CA. An answer to the pharmaceutical industry's media blitz, Living Life Films' "Changing Our Minds" questions society's values while revealing interesting and disturbing truths about psychiatry and the drug industry.

6 May 2010

Lack of physical activity and greater TV viewing time associated with wider retinal venules

It is well known that the lack of physical activity is a risk factor for cardiovascular diseases, but what part does it play in retinal vascular caliber? A team of researchers examined the association of physical activity and television viewing time with retinal vascular caliber and explored the differences in white, black, Hispanic and Chinese racial/ethnic groups.

6 May 2010

Neuroscientist Snyder presents annual Ellis S. Grollman Lecture at UMB

If a drug was developed to block a key protein linked to the onset of Huntington's Disease, it could have a clear path to the part of the brain most affected by the disease, while not bothering other parts of the brain and body, said distinguished neuroscientist Solomon H. Snyder, MD, to an audience of about 300 students and faculty at the University of Maryland, Baltimore (UMB).

6 May 2010

Research reveals reason for ineffectiveness of antioxidants against cardiovascular disease

A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis. By producing a vaccine against the T cell receptors, the researchers have managed to inhibit the development of atherosclerosis in animals.

6 May 2010

ViaCyte granted three new U.S. patents

ViaCyte, Inc., a preclinical stage stem cell engineering company focused on diabetes, announced today that it has received three additional U.S. Patents.

6 May 2010

Multistage nanovector system for siRNA delivery lengthens therapeutic effects of ovarian cancer treatment

New research by scientists at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas M. D. Anderson Cancer Center could make it easier for patients to use a family of promising experimental cancer therapeutics known as small interfering RNA (siRNA).

6 May 2010

VEGF is key target for new anti-angiogenesis drugs, Spanish team reports

Analyzing the expression of particular genes in lung cancers could soon allow researchers to identify groups of patients who are likely to benefit most from treatment with angiogenesis-inhibitor drugs, a Spanish team reports.

6 May 2010

Colonoscopy preparation drugs administered same day as procedure equally effective: Researchers

Researchers at Thomas Jefferson University have found that colonoscopy preparation drugs administered the same day as the procedure are equally effective to those given the night before and the morning of the procedure, but result in less complaints of side effects such as abdominal pain, sleep loss and workday interference.

6 May 2010

IOF WCO-ECCEO10 osteoporosis congress opens in Florence, Italy

A record number of researchers and clinicians from some 100 countries gathered today in Florence, Italy to share new information about osteoporosis, a serious chronic disease which leads to weakened bones and fractures in as many as one in three women and one in five men over the age of fifty.

6 May 2010

Abbott's SPIRIT IV trial results published in The New England Journal of Medicine

Findings from Abbott's SPIRIT IV trial, one of the largest randomized clinical trials comparing two drug eluting stents, with 3,690 U.S.-based patients, were published today in The New England Journal of Medicine.

6 May 2010

Medical Condition News

Bill requiring AEDs be installed in public spaces will save countless lives across Ontario

PTNS performed using Urgent PC Neuromodulation System to receive category 1 CPT reimbursement code

Swedish Cancer Institute, Elekta renew partnership to continue flow of technology, services to cancer patients

Whole grain barley products with low glycemic response provide favourable metabolic benefits

Measurement of finger temperature to assess individual's risk for CVD

Scientists analyze genetic networks of microRNAs in tumors

Study reveals long-term advantages of fast initial weight loss

Promising new generation of contact lenses for myopia control

Phase II trial: TB-402 demonstrates superior antithrombotic activity to enoxaparin

Study confirms long-term durability of endoscopic RFA using HALO system for eradicating Barrett's esophagus

New film on depression, drugs and alternative paths to better mental health

Lack of physical activity and greater TV viewing time associated with wider retinal venules

Neuroscientist Snyder presents annual Ellis S. Grollman Lecture at UMB

Research reveals reason for ineffectiveness of antioxidants against cardiovascular disease

ViaCyte granted three new U.S. patents

Multistage nanovector system for siRNA delivery lengthens therapeutic effects of ovarian cancer treatment

VEGF is key target for new anti-angiogenesis drugs, Spanish team reports

Colonoscopy preparation drugs administered same day as procedure equally effective: Researchers

IOF WCO-ECCEO10 osteoporosis congress opens in Florence, Italy

Abbott's SPIRIT IV trial results published in The New England Journal of Medicine

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News